title: Can quality-adjusted life-years and subgroups help us decide whether to treat late-arriving stroke patients with tissue plasminogen activator?
authors: Daniel A
authors: DA
authors: Waxman
authors: Emmett
authors: E
authors: Keeler
mesh_terms: D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D020521:Stroke / Q000188:drug therapy*; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*
chemical_list: D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator